Increased Cancer Prevalence in Peripartum Cardiomyopathy
Authors:
Open Access
- 1 December 2019
- journal article
- research article
- Published by Elsevier in JACC: Cardiooncology
- Vol. 1 (2) , 196-205
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.
This publication has 44 references indexed in Scilit:
- Pathophysiology and epidemiology of peripartum cardiomyopathyNature Reviews Cardiology, 2014
- Mechanistic Basis of Desmosome-Targeted DiseasesJournal of Molecular Biology, 2013
- Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathyBasic Research in Cardiology, 2013
- Hereditary breast and ovarian cancer susceptibility genes (Review)Oncology Reports, 2013
- MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathyJournal of Clinical Investigation, 2013
- Integrative Genomics Viewer (IGV): high-performance genomics data visualization and explorationBriefings in Bioinformatics, 2012
- BRCA1 is an essential regulator of heart function and survival following myocardial infarctionNature Communications, 2011
- Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathyEuropean Journal of Heart Failure, 2010
- Cadherins as Targets for Genetic DiseasesCold Spring Harbor Perspectives in Biology, 2009
- Peripartum Cardiomyopathy Occurring in a Patient Previously Treated With DoxorubicinThe American Journal of the Medical Sciences, 1997